Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Trial of Lanreotide for the Prevention of Postoperative Pancreatic Fistula

NCT03174353 is registered in ClinicalTrials.gov with University of Washington as lead sponsor.

NCT NCT03174353
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03174353 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Trial of Lanreotide for the Prevention of Postoperative Pancreatic Fistula
Lead sponsor
University of Washington
Phase
Phase 2
Overall status
Completed
Start date
February 20, 2018
Completion date
April 1, 2021
Enrollment
114 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatectomy; hyperglycemia, pancreatic fistula, pancreatic leak, pancreaticoduodenal; fistula